Camargo Carlos Henrique Ferreira, Ladeira Marcelo Araújo, Serpa Rafael Arthur, Jobbins Vinicius Aguiar, Filho Carlos Rory Pucci, Welling Leonardo Christiaan, Teive Hélio Afonso Ghizoni
1 Neurology Service, Hospital Universitário, State University of Ponta Grossa, Ponta Grossa, Brazil.
2 Movement Disorders Unit, Neurology Service, Hospital de Clínicas-Federal University of Parana, Curitiba, Brazil.
Am J Alzheimers Dis Other Demen. 2018 Oct 4;34(2):1533317518802461. doi: 10.1177/1533317518802461.
Patients with Parkinson disease dementia (PDD) have deficits resulting mainly from frontostriatal dysfunction. The aim of this study was to assess the effectiveness of reality orientation therapy (ROT) combined with drug therapy (acetylcholinesterase inhibitors) in PDD treatment and compare it with that of drug therapy alone. Patients (n = 12) with a diagnosis of PDD were divided into 2 groups: group A-drug therapy and ROT; group B-drug therapy alone. Reality orientation therapy was applied weekly for 6 months, and patients were assessed during the same period. Significant improvements in frontostriatal deficits were observed in the group that received the combined therapy, as shown mainly by the scores in verbal fluency in the Consortium to Establish a Registry for Alzheimer's Disease (CERAD) battery ( P = .02) and in attention in Scales for outcomes of Parkinson's Disease-Cognition ( P = .021) and Clock Drawing Test ( P = .037). Patients who received only medication had worse results in constructional praxis recall in the CERAD battery ( P = .037). Our results indicate that ROT may help in the treatment of frontostriatal cognitive deficits and can potentially be used to complement drug therapy.
帕金森病痴呆(PDD)患者的认知缺陷主要源于额纹状体功能障碍。本研究旨在评估现实定向疗法(ROT)联合药物治疗(乙酰胆碱酯酶抑制剂)对PDD的治疗效果,并将其与单纯药物治疗效果进行比较。将12例诊断为PDD的患者分为两组:A组接受药物治疗和ROT;B组仅接受药物治疗。现实定向疗法每周进行1次,共6个月,并在同一时期对患者进行评估。接受联合治疗的组额纹状体缺陷有显著改善,主要表现为阿尔茨海默病注册联合会(CERAD)成套测验中的语言流畅性得分(P = 0.02)、帕金森病认知量表(P = 0.021)中的注意力得分以及画钟试验(P = 0.037)得分。仅接受药物治疗的患者在CERAD成套测验中的结构实践回忆方面结果较差(P = 0.037)。我们的结果表明,ROT可能有助于治疗额纹状体认知缺陷,并有可能用于补充药物治疗。